Your session is about to expire
← Back to Search
Surgical stent for Gingival Recession
Study Summary
This trial will compare the healing of a donor palatal site using L-PRF, H-PRF, or a palatal stent.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Frequently Asked Questions
Does the study accept individuals over 25 years old as participants?
"This study is only open to individuals between the ages of 18 and 65. For those younger than 18 or older than 65, there are 12 other trials that may be suitable for them."
What is the aggregate figure of people participating in this trial?
"Affirmative. The information hosted on clinicaltrials.gov has established that this medical investigation, which was first advertised in February 2021, is actively seeking participants. Approximately 30 people are needed from a single site for enrollment."
Are there presently any opportunities to join this clinical experiment?
"As per the clinicaltrials.gov records, this medical trial is actively on the lookout for eligible participants. The experiment was initially posted in February of 2021 and experienced its last update just recently in March 2022."
Has the FDA given its stamp of approval to this particular Surgical stent?
"As this is a Phase 1 trial, where there are limited data supporting safety and efficacy, our Power team assigned it a score of 1 on the risk scale."
Do I fulfill the requirements to participate in this clinical research?
"This scientific experiment seeks 30 human test subjects aged 18-65 who suffer from a particular medical condition. Furthermore, successful candidates must have optimal oral hygiene (as indicated by plaque and bleeding indexes of less than 20%), be able to withstand alginate impressions or retainer wear, and not require any additional surgical procedures or painkillers at the same site."
Share this study with friends
Copy Link
Messenger